Axsome Therapeutics Announces FDA Acceptance and Priority Review of Supplemental New Drug Application for AXS-05 for the Treatment of Alzheimer’s Di…

FDA grants AXS-05 Priority Review designation and sets PDUFA action goal date of April 30, 2026 NEW YORK, Dec. 31, 2025 ...

Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-12 in Narcolepsy Supporting NDA Submission

New Drug Application (NDA) submission on track for January 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome ...
IEEE

Coupling Mechanism Analysis and Stabilization Improvement for Hybrid System With GFL and GFM Converter Under Grid Faults

Abstract: The dynamic coupling between grid-following (GFL) and grid-forming (GFM) converters, as well as their interaction with synchronous generators (SGs), may have a significant influence on the ...
IEEE

Using Radial Basis Function Neural Network With Weight Memory Mechanism: Nonlinear System Identification

Abstract: The radial basis function neural network (RBFNN) is a learning model with better generalization ability, which attracts much attention in nonlinear system identification. Compared with the ...
2UrbanGirls on MSN

Gonadorelin: A peptide gateway into endocrine and reproductive research

Peptides have long attracted attention in the scientific community due to their structural simplicity yet vast range of ...